Experiments by Xiong et al. (2023) have shown that astragaloside IV-stimulated endothelial progenitor cells-derived exosomes can enhance the wound healing rate, collagen deposition, and increase the number of CD31 and α-SMA positive cells, thereby accelerating wound healing in type 1 diabetes. This evidence concerns the gene PECAM1 and type 1 diabetes mellitus.